"Somos el INSTITUTO DE GINECOLOGÍA de la ciudad de Rosario, un selecto grupo de profesionales médicos dedicados a la salud y el cuidado de la mujer en en todas las subespecialidades de la ginecología y otras áreas médicas relacionadas; como así también a la atención integral de pacientes con problemas reproductivos. Ofrecemos las más modernas técnicas de prevención, diagnóstico y tratamiento en infertilidad."

During the past decade, Instituto de Ginecología conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Ginecología" are "Cervical Dysplasia" (2 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (2 trials) and "HSIL" (2 trials). Many other conditions were trialed in "Instituto de Ginecología" in a lesser frequency.

Most popular intervention types in "Instituto de Ginecología" are "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "VGX-3100" (2 trials), "CELLECTRA™-5PSP" (1 trials) and "Electroporation (EP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Ginecología" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto de Ginecología". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Ginecología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Ginecología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".